Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar
Takashi Yamamura(National Center of Neurology and Psychiatry), Benjamin Greenberg(Centre Hospitalier Universitaire de Martinique), de Sèze(Hôpital d'Hautepierre), Michael R. Yeaman(UCLA Medical Center), Brian G. Weinshenker(Mayo Clinic in Arizona), Kristina Weber(Medizinische Hochschule Hannover), Francesco Patti(University of Catania), H.-Christian von Büdingen(Roche (Switzerland)), Xiujing Kou(Roche (Switzerland)), Patricia Lobo(Aecom (United Kingdom))
Cited by 60
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k